Accelmed Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Accelmed has acquired 1 company. It has also invested in 6 others.

Accelmed’s most common sectors for investment aremedical products (67%) and life science (12%) . The Firm’s most common investment types include venture (45%) and growth capital (28%). In total, Accelmed has invested in 9 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2024 when it acquired Bioventus - Advanced Rehabilitation Business for $45M.

In the last 3 years, Accelmed has exited 5 companies. The Firm’s most common exit type is trade sale (60%). Accelmed’s largest (disclosed) exit occurred in 2024 when it sold EndoGastric Solutions for $105M.

Join Mergr to view Accelmed’s full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity18
    • M&A Sell Activity5
  • Total Sectors Invested 5
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 8
  • M&A Advisors 2

Accelmed

Accelmed

848 Brickell Ave, #901,
Miami, Florida 33131
United States
(305) 854-6815
www.accelmed.com
info@accelmed.com

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.


Investment Criteria

Sectors of Interest: Business Services, Information Technology, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Nordic, Middle East

Transaction Criteria Min Max
Target Revenue 20 70
Target EBITDA - -
Investment Size 20 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.8/yr) # 9 2 4 1 1 1 18
vol $25M $45M $70M
Sell (1.0/yr) # - - 1 - 2 2 5
vol $105M $105M
  23

Most Recent M&A

Company Date Value Type
Bioventus - Advanced Rehabilitation Business 2024-10-01 45M USD Divestiture
, United States
Trukera Medical 2024-07-23 - Trade Sale
Southlake, Texas · www.trukera.com
EndoGastric Solutions, Inc. 2024-07-01 105M USD Trade Sale
Redmond, Washington · www.endogastricsolutions.com
Valcare Medical 2023-08-01 - Secondary Sale
Herzliya, Israel · www.valcaremedical.com
Medminder Systems, Inc. 2023-04-19 - Trade Sale
Norwood, Massachusetts · www.medminder.com
Minerva Surgical, Inc. 2023-02-09 - Stake Purchase
Santa Clara, California · www.minervasurgical.com
SKNV, Inc. 2022-11-14 - Growth Capital
Pompano Beach, Florida · www.sknv.com
Click Therapeutics, Inc. 2021-10-22 - Venture
New York, New York · www.clicktherapeutics.com
Veranex 2021-06-16 - Growth Capital
Raleigh, North Carolina · www.veranex.com
Neuropace, Inc. 2021-04-21 - IPO
Mountain View, California · www.neuropace.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 8 (62%) 45M (100%) 12 (67%) 70M (100%)
Information Technology 2 (15%) - 2 (11%) -
Life Science 1 (8%) - 2 (11%) -
Business Services 1 (8%) - 1 (6%) -
Software 1 (8%) - 1 (6%) -
Total 13 $45M 18 $70M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 10 (77%) 45M (100%) 14 (78%) 70M (100%)
  New York 3 (23%) - 3 (17%) -
  Massachusetts 2 (15%) - 3 (17%) -
  California 1 (8%) - 2 (11%) -
  Pennsylvania 1 (8%) - 1 (6%) -
  North Carolina 1 (8%) - 1 (6%) -
  Florida 1 (8%) - 1 (6%) -
  Texas - - 1 (6%) 25M (36%)
  Washington - - 1 (6%) -
Israel 3 (23%) - 4 (22%) -
Total 13 $45M 18 $70M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 7 (54%) - 8 (44%) -
Growth Capital 2 (15%) - 5 (28%) -
Stake Purchase 2 (15%) - 2 (11%) -
Divestiture 1 (8%) 45M (100%) 1 (6%) 45M (64%)
Going Private - - 1 (6%) 25M (36%)
Secondary Buyout 1 (8%) - 1 (6%) -
Total 13 $45M 18 $70M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (40%) 105M (100%)
IPO 1 (20%) -
Secondary Sale 1 (20%) -
Trade Sale 1 (20%) -
Total 5 $105M

Top M&A Advisors

Legal Deals
Stevens & Lee
 1
Jones Day
 1

Deal Values

buy # Total
< $100M 2 $70M
TOTAL $70M
Largest Bioventus - Advanced Rehabilitation Business
$45M (2024-10-01)
sell # Total
$100M to $1B 1 $105M
TOTAL $105M
Largest EndoGastric Solutions, Inc.
$105M (2024-07-01)

M&A Connections

Deals
Acquired from
Investor(s)
6%
1 (6%)
Strategic(s)
6%
1 (6%)
Exited to
Strategic(s)
60%
3 (60%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2009

Specialist/Generalist

Specialist

Leadership

Uri Geiger

Co-Founder & Managing Partner

Stephen Rubin

General Partner

Guy Ohad

Chief Medical Officer

Susan Alpert

Chief Regulatory Officer

Ilan Ben-Oren

Chief Technology Officer

FAQ

When was Accelmed founded?

Accelmed was founded in 2009.

What type of investor is Accelmed?

Accelmed is a private equity firm.

Where is Accelmed headquartered?

Accelmed is headquartered in Miami, Florida.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal